![Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/068b93c0-589b-4655-81f2-8c12483f8b7b/jne_975_f2.gif)
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library
![Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c37b5bbf-7690-4a51-a7b9-92c2981cb067/jne_975_f1.gif)
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library
![Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors](https://pub.mdpi-res.com/molecules/molecules-28-04848/article_deploy/html/images/molecules-28-04848-ag.png?1687163652)
Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors
![Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/75611810-c1ce-4ba6-bc14-75f1bab163fc/jne_975_f5.gif)
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library
![Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors](https://pub.mdpi-res.com/molecules/molecules-28-04848/article_deploy/html/images/molecules-28-04848-g001.png?1687163643)
Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors
![Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical Neuroscience Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.2c00806/asset/images/medium/cn2c00806_0008.gif)
Alleviation of Cocaine Withdrawal and Pertinent Interactions between Salvinorin-Based Antagonists and Kappa Opioid Receptor | ACS Chemical Neuroscience
![Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.npp.1300811/MediaObjects/41386_2005_Article_BF1300811_Fig3_HTML.gif)
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
![WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents](https://patentimages.storage.googleapis.com/f5/77/e6/0b8ccb036fcf7c/imgf000018_0001.png)
WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents
![Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpp.2017.205/MediaObjects/41386_2018_Article_BFnpp2017205_Fig1_HTML.jpg)
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology
![Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? | Nature Reviews Endocrinology Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fncpendmet0270/MediaObjects/41574_2006_Article_BFncpendmet0270_Fig1_HTML.jpg)
Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? | Nature Reviews Endocrinology
![Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal](https://jpet.aspetjournals.org/content/jpet/288/1/260/F1.medium.gif)
Dynorphin A1–13 Causes Elevation of Serum Levels of Prolactin Through an Opioid Receptor Mechanism in Humans: Gender Differences and Implications for Modulation of Dopaminergic Tone in the Treatment of Addictions | Journal
![Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors](https://www.mdpi.com/molecules/molecules-28-04848/article_deploy/html/images/molecules-28-04848-g006-550.jpg)
Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors
![Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41386-018-0015-y/MediaObjects/41386_2018_15_Fig1_HTML.jpg)
Preclinical evaluation of the kappa-opioid receptor antagonist CERC-501 as a candidate therapeutic for alcohol use disorders | Neuropsychopharmacology
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders | SpringerLink
![Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnpp.2017.205/MediaObjects/41386_2018_Article_BFnpp2017205_Fig3_HTML.jpg)
Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence | Neuropsychopharmacology
Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance | ACS Chemical Neuroscience
![Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4879e320-311c-49c0-9c80-1f759b53f1fd/jne.v35.12.cover.jpg?trick=1702285067693)
Opioid Receptor Subtypes Involved in the Regulation of Prolactin Secretion During Pregnancy and Lactation - Andrews - 2003 - Journal of Neuroendocrinology - Wiley Online Library
![WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents](https://patentimages.storage.googleapis.com/ac/1a/d0/9968a708391f19/imgf000031_0001.png)
WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents
![Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.npp.1300811/MediaObjects/41386_2005_Article_BF1300811_Fig2_HTML.gif)
Nalmefene Induced Elevation in Serum Prolactin in Normal Human Volunteers: Partial Kappa Opioid Agonist Activity? | Neuropsychopharmacology
![Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates. - Abstract - Europe PMC Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8175454/bin/nihms-1694875-f0001.jpg)
Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates. - Abstract - Europe PMC
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
![Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors Molecules | Free Full-Text | The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depressive-like Behaviors](https://www.mdpi.com/molecules/molecules-28-04848/article_deploy/html/images/molecules-28-04848-g003-550.jpg)